Home›Stock Screener›Krsnaa Diagnostics›Quarterly Results

Krsnaa Diagnostics Quarterly Results

Latest Quarter Net Profit
₹25 Cr
QSept 2026
Quarterly Results

Krsnaa Diagnostics quarterly results. In Sept 2026, Krsnaa Diagnostics (KRSNAA) reported revenue ₹277 Cr and net profit ₹25 Cr — revenue +31.9% YoY. For annual financials, live price and key ratios, visit Krsnaa Diagnostics screener.

KRSNAA Quarterly Results — Revenue, Profit & EPS Highlights

Krsnaa Diagnostics latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View KRSNAA price range for the annual high/low range and current price position.

  • Revenue of ₹277 Cr in Sept 2026 (+23.7% vs Mar 2026, +31.9% vs Sept 2025)
  • Net Profit of ₹25 Cr in Sept 2026 (-40.5% vs Mar 2026, +4.2% vs Sept 2025)
  • EBITDA of ₹77 Cr in Sept 2026 (-10.5% vs Mar 2026)
  • Operating Margin of 26.0% in Sept 2026 (-2.0pp vs Mar 2026)
  • Earnings Per Share of ₹7.64 in Sept 2026 (-40.6% vs Mar 2026)

Krsnaa Diagnostics Quarterly Results — Revenue, EBITDA, Net Profit & EPS

KRSNAA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 277 224 243 210 191 23.7% 31.9%
Net Profit (₹ Cr) 25 42 17 24 21 - -
EBITDA (₹ Cr) 77 86 65 63 57 - -
EPS (₹) 7.64 12.86 5.10 7.38 6.40 - -
Operating Margin (%) 26.0% 28.0% 25.0% 29.0% 28.0% - -

KRSNAA Share Price Trend — 1-Year Movement Across Quarterly Results

Krsnaa Diagnostics 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore KRSNAA stock price history to track price trends across different timeframes.

Profitability Ratios

Profit Margin 9.0%
EBITDA Margin 27.8%
Operating Margin 26.0%
ROE (Annual) 10.2%

Balance Sheet Highlights

Total Assets ₹1,824 Cr
Total Equity ₹980 Cr
Current Assets ₹ Cr
Current Liabilities ₹568 Cr

Cash Flow Analysis

Operating Cash Flow ₹143 Cr
Investing Cash Flow ₹-396 Cr
Financing Cash Flow ₹279 Cr
Net Cash Flow ₹26 Cr

Current Market Data

Current Price ₹515.65
Exchange NSE
Last Updated Nov 19, 2026

KRSNAA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Krsnaa Diagnostics latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores